Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR
Stanford University
40 participants
Apr 1, 2025
INTERVENTIONAL
Conditions
Summary
The primary goal of this project is to study the feasibility of a brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of human brains. The study will also allow us to compare the imaging performance of the investigator's brain-dedicated PET insert against a commercial whole-body permanently integrated PET/MRI system using a common radiopharmaceutical.
Eligibility
Inclusion Criteria5
- Whole body radiation dose within the last year of less than 5000 mrem
- Subjects intended for injected tracer studies (not associated with another study) must be willing/able to undergo injection of 6-12 mCi of either FDG or Neuraceq radiotracer. Both tracers are FDA approved
- Subjects will be at least 21 years of age
- Subject provides written informed consent
- Subject is deemed healthy by the PI by via self-reported questionnaire
Exclusion Criteria4
- For patients who will be receiving a tracer injection, no known allergy to the imaging agents
- Participant has a history of or current diagnosis of cancer
- Participant is pregnant or nursing
- Metallic implants (contraindicated for MRI)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
1. Informed consent will be obtained before beginning any study procedures. 2. Participants will receive a small quantity of an FDA approved radiotracer. The PET insert is placed within a 3T MRI scanner, where PET and MRI imaging will be completed.
1. Informed consent will be obtained before beginning any study procedures. 2. Participants who have received radiotracer for another PET imaging system. The PET insert is placed within a 3T MRI scanner, where PET and MRI imaging will be completed.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04383808